Effects of Arsenic on Keratinocytes in a Skin Equivalent Model
NCT00166946 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2005-12-21
Summary
We popose that arsenic-induced lymphocytes dysfunction plays an important role in biological mechanisms of arsenical Bowen's disease.
Conditions
- Bowen Disease
Interventions
- PROCEDURE
-
foreskin from healthy adults for organotypic culture
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Hsin-Su Yu, MD PHD · National Taiwan Univesity Hospital, Dept. of Dermatology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- ECT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-06-30
- Completion
- 2008-01-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Pilot Study of Protein Profiling of the Human Epidermal Cells After Ultraviolet Irradiation
NCT00397436 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Calcinosis Reduction by Pyrophosphate in SSC
NCT04966416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Gasdermin D Expression in Generalized Vitiligo Patients After Narrow-band Ultraviolet B Therapy
NCT06546059 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cutaneous DNA Damage Caused by UV-A Irradiation
NCT00864955 ·Status: COMPLETED ·Phase: NA
-
The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis
NCT00509314 ·Status: UNKNOWN
-
A Novel Oral Natural Extract for the Treatment of Senile Purpura
NCT01183910 ·Status: UNKNOWN ·Phase: NA
-
Molecular Effects of Topical Calcipotriene on Morphea
NCT02411643 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effectiveness of the Henna Application in Patients with Hand-Foot Syndrome: Nested Case-Control Study
NCT06832501 ·Status: COMPLETED
-
Trem-1 and Ultraviolet Radiation-induced Immune Suppression
NCT05020496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
NCT07228429 ·Status: RECRUITING
-
Role of CD7 in Skin Inflammation and Psoriasis
NCT00162825 ·Status: COMPLETED
-
Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
NCT01276314 ·Status: COMPLETED ·Phase: NA
-
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
NCT00213525 ·Status: COMPLETED
-
The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis
NCT02480335 ·Status: COMPLETED ·Phase: PHASE4
-
Calcinosis in a Single-Center Scleroderma Population
NCT02062125 ·Status: COMPLETED
-
Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
NCT00555633 ·Status: COMPLETED
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING
-
Skin Denervation in Systemic Lupus Erythematosus
NCT00155532 ·Status: COMPLETED ·Phase: PHASE1
-
ST266 in UV-induced Inflammation
NCT02389777 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of RANKL Inhibition on UV-induced Immunosuppression
NCT01978483 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Compound Isolated From Cock's Comb and Its Effect on Arsenical Palmar Keratosis
NCT03635853 ·Status: UNKNOWN ·Phase: PHASE2
-
The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
NCT05156138 ·Status: UNKNOWN
-
Fresolimumab In Systemic Sclerosis
NCT01284322 ·Status: COMPLETED ·Phase: PHASE1
-
Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon
NCT03972566 ·Status: UNKNOWN